Pre-Exposure Prophylaxis PrEP

More documents

Recommendations

Info

Miller CJ, et al. J Virology 2005 : 79; 9217–9227
Page 1 and 2: Narin Hiransuthikul MD, PhDDep. Pre
Page 3 and 4: THAILANDAdult (15-49 years) HIV Pre
Page 5 and 6: December 2009
Page 7 and 8: ้วิธีการต่า
Page 9 and 10: ่่้การใช้ยา
Page 11 and 12: • The ongoing use of one or two a
Page 16 and 17: Potential types of PrEPHow are the
Page 18 and 19: Properties of an ideal PrEP agent
Page 20 and 21: Truvada® forPrEP• Combination of
Page 22 and 23: ูเพร็พแบบไม
Page 24 and 25: ทําไม ทาไม “เ
Page 26 and 27: ความท้าทายอ
Page 28 and 29: ่ื่สรปเรื่อ
Page 30 and 31: เพ็พPost-Exposure Prophylax
Page 32 and 33: Last updated March 27, 2012;last re
Page 35 and 36: Post-Exposure ProphylaxisThe World
Page 37 and 38: ้ความเสี่ยง
Page 39 and 40: Risk of HIV Transmission afterOccup
Page 41 and 42: Risk Factors for HIV Occupational T
Page 43 and 44: Risk of HIV Sexual Transmission•
Page 45 and 46: Other Cofactors• Source HIV viral
Page 47 and 48: ููู้แนวทางป
Page 49 and 50: Determination of eligibility for PE
Page 51 and 52: HIV Occupational ExposurePEP or No
Page 53: Choices of ART for PEP• However,
Page 56 and 57: Follow-up of HCP exposed to known o
Page 58 and 59: ื็แนวทางการ
Page 60 and 61: ูุตารางที่ 2.1
Page 62 and 63: Situations when nPEP is consideredB
Page 64 and 65:
Choices of ART for nPEP• Newer dr
Page 67 and 68:
ARV Regimens for HIV nPEPPreferred
Page 69 and 70:
Major Differences betweenNon-occasi
show all

Pre-Exposure Prophylaxis PrEP

Create successful ePaper yourself

Delete template?

Save as template?